Nachrichten zur Moderna Inc. Aktie

Zürich (www.aktiencheck.de) - Moderna-Aktienanalyse von der UBS: Aktuelle Bewertung UBS hat das Kursziel für die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…

Moderna Aktie: Wachsender Wettbewerb und regulatorische Hürden - Bernstein mit vorsichtiger Einschätzung

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Sanford C. Bernstein & Co: Aktuelle Bewertung Das US-Analysehaus Bernstein hat die Berichterstattung über Moderna Inc.…

NFLX, TSM, AXP, MRNA, TSLA: Top 5 Trending Stocks Today - American Express (NYSE:AXP), Moderna (NASDAQ:MRNA)

S. markets ended Thursday with mixed performance: the Dow Jones Industrial Average climbed 0.4% to 43,239.05.…

Moderna Stock Falls 20% in a Month: Time to Sell or Hold?

Shares of MRNA have been declining after it lowered its long-term financial guidance. It has also pushed its breakeven point…

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines By Reuters

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines…

MRNA DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Moderna, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA

NEW YORK, Oct. 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

October 8, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRNA

NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

Moderna, Cenra Healthcare enter JV to promote mRNA respiratory vaccine in Taiwan

…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)…

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Metagenomi Inc.

Robbins LLP is Investigating Allegations that Metagenomi Inc. (MGX) Misled Investors Regarding its Relationship with Moderna, Inc.…

ROSEN, LEADING INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

NEW YORK, Sept. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Down 13% in 1 Day, Is Moderna Stock in Trouble?

Theres no hope of it recovering to its prior heights anytime soon.…

Down 13% in 1 Day, Is Moderna Stock in Trouble? @themotleyfool #stocks $MRNA

Theres no hope of it recovering to its prior heights anytime soon.…

Moderna: Still Bullish View

…

Moderna, Inc. REMINDER – MRNA Stockholders Should Contact Robbins LLP for Information About the Moderna, Inc. Class Action and Pending Lead Plaintiff Deadline

Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine…

Moderna: Aktie springt hoch – das beflügelt

Die Moderna-Aktie stieg am Dienstag um über vier Prozent.…

Moderna: Zulassung des aktualisierten Covid-19-Impfstoffs durch Health Canada - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

ROSEN, A LEADING LAW FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Lost Money on Moderna, Inc. (MRNA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna"…

Moderna: Kurszielsenkung - Aktienanalyse

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Morgan Stanley: Morgan Stanley senkt in einer aktuellen Aktienanalyse das Kursziel für die Aktie von…